A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain
Status:
Recruiting
Trial end date:
2023-07-07
Target enrollment:
Participant gender:
Summary
This is a Phase 3, Multicenter, 22-Week, double-blind and 30-Week open label Study to
Evaluate the Efficacy and Safety of X0002 Spray in relief of pain of subjects with
Osteoarthritis of the Knee.